Friday, July 1, 2011

Health News: [cancer]


Dendreon Put-Options Trading Surges Before Medicare Approval
BusinessWeek Thu, 30 Jun 2011 13:54 PM PDT
Trading of put options on Dendreon Corp., the drugmaker whose only product is Provenge, rose to a seven-month high before Medicare approved paying for the prostate cancer treatment.

Medicare to cover Dendreon's prostate drug
Reuters Thu, 30 Jun 2011 13:48 PM PDT
WASHINGTON (Reuters) - The Medicare health insurance program will fully cover Provenge, Dendreon Corp's expensive treatment for advanced prostate cancer, U.S. regulators said on Thursday.

Medicare Will Pay For Avastin, Despite FDA Decision
The Huffington Post Thu, 30 Jun 2011 13:47 PM PDT
Medicare will continue coverage of Roche Holdings' drug Avastin for breast cancer regardless of what U.S. health regulators decide about the medicine, a spokesperson for the health insurer said.

Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE
PR Newswire via Yahoo! Finance Thu, 30 Jun 2011 13:47 PM PDT
Dendreon Corporation today announced significant milestones that support broad availability for on-label use of PROVENGE® , the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer . Â

Medicare confirms payment for prostate cancer drug
Washington Examiner Thu, 30 Jun 2011 13:44 PM PDT
The Associated Press The Associated Press WASHINGTON Medicare officials are confirming that the program will pay for the prostate cancer drug Provenge, an innovative therapy that costs $93,000 and extends life about four months. The decision from the Centers for Medicare and Medicaid repeats an earlier proposed ruling that the biotech drug from Dendreon Corp. is a "reasonable and necessary ...

Connection between cellphone use and cancer-causing cells unclear
The Daily Universe Thu, 30 Jun 2011 13:42 PM PDT
The International Agency for Research and Cancer found minimal association between carcinogenic cells related with cell phone use after a week-long expert panel discussion. Many other factors are thought to increase likeliness of cancer-causing cells, including genes, use and exposure. The panel’s chairman, Jonathan Samet of the University of Southern California, told the Washington Post, [...]

UC Davis Cancer Center Finding Suggests Way To Make Bladder Cancer Cells More Susceptible To Chemotherapy
redOrbit Thu, 30 Jun 2011 13:39 PM PDT
Improving efficacy of drugs would boost post-surgery survivorship Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA â€" called microRNA â€" play key roles in some of the deadliest types of cancer. In the current ...

Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug
Bloomberg Thu, 30 Jun 2011 13:37 PM PDT
Dendreon Corp. (DNDN) ’s prostate cancer medicine Provenge should be covered by the U.S. health plan for the elderly and disabled, regulators said, confirming a proposal from March.

Tasmanian Devils Now Threatened by Extinction
Gather Thu, 30 Jun 2011 13:35 PM PDT
The marsupials known as Tasmanian devils are in danger of becoming extinct, thanks to the spread of a contagious cancer called DFTD - Devil Facial Tumor Disease. The cancer, which surfaced about 15 years . . .

Esplanade closure during Race for Life
Aberdeen City Council News Thu, 30 Jun 2011 13:35 PM PDT
Beach Esplanade, Links Road and Accommodation Road will be closed to traffic during part of Sunday 03 July to allow the Cancer Research UK Women's 5km Race for Life to go ahead safely. 2011/06/30 21:15:51




See more health stories that match my keyword
Visit Yahoo! Health


You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment